SEMGTD – Synthetic GLP-1 Receptor Agonist Peptide

Research Use Only – Not for Human or Veterinary Administration

Product Overview

SEMGTD is a synthetic GLP-1 receptor agonist peptide provided as a sterile, lyophilized powder for use in non-clinical research environments. This analog is formulated for extended stability and albumin-binding activity, making it suitable for in vitro investigations into incretin signaling, receptor activation, and related metabolic pathways.

Compound Specifications

Laboratory Research Applications

SEMGTD is used in controlled research models involving:

• Glucose Regulation & Insulin Signaling: Receptor pathway studies on pancreatic beta-cell signaling and glucose homeostasis
• Appetite & Gastrointestinal Motility Models: Investigations of satiety mechanisms in CNS-based assays
• Pharmacokinetics & Receptor Binding Assays: Evaluation of duration, absorption, and GLP-1R receptor activation in non-human systems
• Metabolic Peptide Comparisons: Research comparing GLP-1 analogs with GIP, dual-agonists, or peptide combinations

All research uses are non-clinical and exploratory in nature.

Handling & Preparation Guidelines

• Reconstitute under sterile laboratory conditions using approved diluent
• Store unopened vials at –20°C, in a dark, dry environment
• Avoid repeated freeze–thaw cycles
• Use aseptic technique and record batch numbers per lab SOPs

Compliance & Legal Restrictions

• Not for human or animal use
• Not intended for therapeutic, diagnostic, or dietary applications
• Use must follow all local, state, and institutional research guidelines

Packaging & Documentation

• Sterile sealed vials with tamper-evident caps
• Lot-labeled with expiration and traceability info
• Certificate of Analysis (COA) available on request

View Lab Result

This compound is not FDA approved and is not intended for diagnostic, dietary, therapeutic, or cosmetic applications.